# Endometrium Immunomodulation by in Utero Administration of Peripheral Blood Mononuclear Cells

> **NCT04648566** · NA · COMPLETED · sponsor: **Fertilys** · enrollment: 423 (actual)

## Conditions studied

- Infertility

## Interventions

- **PROCEDURE:** Intrauterine administration of hCG-activated peripheral blood mononuclear cells
- **PROCEDURE:** Intrauterine administration of sperm washing medium

## Key facts

- **NCT ID:** NCT04648566
- **Lead sponsor:** Fertilys
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-22
- **Primary completion:** 2020-02-01
- **Final completion:** 2020-02-01
- **Target enrollment:** 423 (ACTUAL)
- **Last updated:** 2020-12-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04648566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04648566, "Endometrium Immunomodulation by in Utero Administration of Peripheral Blood Mononuclear Cells". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04648566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*